U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process

U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process

U.S. Precision Medicine, Inc. (USPM) has signed a Memorandum of Understanding (MOU) to deploy microNeb's advanced inhaler technology to expedite the uptake of its new cancer drug candidate currently in the Investigational New Drug (IND) process. - July 16, 2024 - microNeb, Inc.

MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy

MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy

Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side effects such as nausea and GI discomfort while driving increased weight loss. - July 16, 2024 - Courage Therapeutics

SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board

SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board

SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx

Huntington Study Group Announces Launch of LEAD-HD Observational Study

Huntington Study Group Announces Launch of LEAD-HD Observational Study

The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) today announce the release of their newest Patient Reported Outcomes (PRO) study, LEAD-HD. This observational study was developed collaboratively with the University of Rochester Center for Health +... - July 15, 2024 - Huntington Study Group

Lit Weed Delivery Announces Partnership with Golden Grams Cannabis Boutique

Lit Weed Delivery Announces Partnership with Golden Grams Cannabis Boutique

Lit Weed Delivery is excited to disclose a new partnership with Golden Grams Cannabis Boutique, a collaboration set to revolutionize the cannabis purchasing experience for customers throughout the Greater Toronto Area and Canada. - July 15, 2024 - Lit Weed Delivery

GDP Training Course is Now Ready and Free

Pharma Lessons’ new GDP training is finally out. It covers the guidelines for wholesale distribution of medicinal products as an important part of the supply chain management. The course is a summary of the most recent GDP (Good Distribution Practice) guidelines based on Articles 84 and... - July 15, 2024 - Pharma Lessons

NuvOx Pharma LLC Announces Authorization of ARDS Trial from Health Canada

NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic NanO2 for mild respiratory distress in Phase Ib and ARDS in Phase II Trials. Evan Unger, MD, CEO of NuvOx, said, “Acute Respiratory Distress... - July 12, 2024 - NuvOx Therapeutics

LGBTQ+ Screenplay Shining Light on Opioid Crisis Unveils Title & New Website

Multi-award winning film script has a new title and a new website to promote the message of hope. Inspired by true events, the screenplay depicts the harsh realities of opioid addiction and the challenging road to recovery those struggling must face. - July 02, 2024 - Worthy

Tesla BioHealing, Inc. Achieves ISO 13485 QMS Certification

Tesla BioHealing, Inc. Achieves ISO 13485 QMS Certification

Tesla BioHealing, Inc. manufactures unique wellness devices while using a quality management system recently certified by American Systems Registrar (ASR). - July 01, 2024 - Tesla BioHealing, Inc.

igus® Presents a Unique 4-Year Guarantee for Their Products

Even greater operational reliability and sustainability thanks to billions of test cycles in their in-house laboratory. - June 28, 2024 - igus Singapore Pte Ltd

Abel Womack CEO Announces His Retirement and Successor

After 50 years with Abel Womack, John Croce, CEO retires. - June 27, 2024 - Abel Womack Inc

Daicel Arbor Biosciences Launches New myTXTL® Kits to Accelerate Protein Expression

Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS... - June 27, 2024 - Daicel Arbor Biosciences

Natural Scientific Launches Amazon Storefront to Revolutionize Nutritional Supplement Market

Natural Scientific Launches Amazon Storefront to Revolutionize Nutritional Supplement Market

Privately-owned American company introduces a new range of natural, filler and additive-free vitamins and minerals. - June 26, 2024 - Natural Scientific Labs LLC

SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility

SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility

SYNAPS Dx has moved to a new, state-of-the-art facility in Rockville, MD, to meet growing demand and enhance patient care. The larger space and advanced infrastructure will support more diagnostic samples and ensure timely, accurate Alzheimer's and dementia diagnoses. Fully qualified for high-complexity clinical lab testing, the facility boosts diagnostic capabilities. The expansion will also advance the DISCERN™ test, a minimally invasive tool distinguishing Alzheimer's from other dementias. - June 26, 2024 - SynapsDx

Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science

Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science

Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group

I Holland Launches Tooling Safe Disposal & Recycling Service

I Holland, has launched its new Safe Disposal &Recycling Service. This valuable service is designed to ensure the safe, secure, and environmentally responsible destruction of obsolete or worn-out tooling, enhancing both the integrity and sustainability of pharmaceutical manufacturing. Their... - June 23, 2024 - I Holland Ltd.

VITAMIST® Unveils New Enhanced Website for Premium Vitamin Oral Sprays

VITAMIST®, inventor of vitamin oral sprays, is excited to announce the launch of its newly redesigned website, www.vitamist.com. This significant update underscores VITAMIST's commitment to providing high-quality, science-backed vitamin solutions. - June 13, 2024 - VitaMist

KIRON.AI Launches Book “NEOBANK Navigating the Future of Banking” by Author and Bank Owner Ronald Ingram

KIRON.AI Launches Book “NEOBANK Navigating the Future of Banking” by Author and Bank Owner Ronald Ingram

KIRON.AI, a Henderson, Nevada-based AI Health & Wealth company launches “NEOBANK Navigating the Future of Banking,” a groundbreaking book exposing the history and predicting the future of banking from author Ronald Ingram’s perspective as a bank owner, historian, futurist and polymath. The company KIRON.AI employs artificial intelligence (AI) to discover, uncover, develop and deploy protocols, tools and information to enhance human wealth and health preservation and generation. - June 11, 2024 - Kiron.AI

Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.

Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.

New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation

Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com

Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of... - June 07, 2024 - Cayman Chemical Company

FlowSense: Affordable Antibiotic Testing to Transform the Honey Industry from Biorex Food Diagnostics

Biorex Food Diagnostics announced today the launch of its cutting-edge FlowSense product line, with the first phase designed specifically for the honey industry. The new FlowSense test products introduce a comprehensive range of antibiotic test panels, providing honey producers with an innovative... - June 07, 2024 - Biorex Food Diagnostics

Megalabs Acquires Majority Interest and Control of DS Laboratories

Megalabs Acquires Majority Interest and Control of DS Laboratories

Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories (“DS Labs”), a leading dermatology company focused on science backed hair care across 50+ countries. This strategic move enhances Megalabs' position in the global dermatology market and the US. - May 31, 2024 - Megalabs

LGBTQ Screenplay Secures Oscar-Nominated Director Strengthening the Team Supporting the Films Message

Following its fourth film festival win, the writer of "You Are What You Love" recently announced the addition of Bradley Raymond to the team working to get the story to screen. The sapphic drama is based on true events about a young lesbian struggling with opioid addiction and sheds much... - May 30, 2024 - Worthy

Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List

Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List

Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List Sosemo LLC has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2024. This prestigious award is presented by the Financial Times and Statista Inc., the... - May 30, 2024 - Sosemo

New GVP Training with Certificate

Pharma Lessons has launched a new Good Pharmacovigilance Practice Training with certificate. The training has been developed from scratch and is quite different from the free GVP course that the company currently offers on the corporate website. It is a brand new product that features new content,... - May 29, 2024 - Pharma Lessons

Jusha International and Dextro Imaging Form Strategic Partnership

Jusha International and Dextro Imaging Form Strategic Partnership

Jusha International Collaborates with Dextro Imaging Specialists, Revolutionizing Radiology with Lower Costs and Enhanced Quality - May 28, 2024 - Dextro

Evolution Analytics Awarded “Most Innovative Data & Analytics Consultancy” by Acquisition International

Evolution Analytics Awarded “Most Innovative Data & Analytics Consultancy” by Acquisition International

Evolution Analytics is Recognized for Pioneering Excellence in Data Solutions and Analytics Consulting Services - May 24, 2024 - Evolution Analytics

Creative Biolabs Opens Applications for the 2024 Scholarship Program

Creative Biolabs, a leading CRO, is proud to announce the opening of applications for its 2024 scholarship program. This initiative aims to provide financial assistance to students within the biotechnology industry, supporting their academic pursuits and research endeavors. - May 19, 2024 - Creative Biolabs

GENINVO Launches Its Latest Offering – DocWrightAI

GENINVO, a leading provider of life science products and business solutions announced the launch of its new, on-demand service: DocWrightAI. GENINVO understands the various challenges in generating clinical documents. The time taken to draft clinical documents with accuracy and compliance has... - May 18, 2024 - GenInvo, Inc.

Snova's Halal Extract Wins Its Third Consecutive Gold at the Monde Selection

Snova's Halal Extract Wins Its Third Consecutive Gold at the Monde Selection

Snova’s Halal Extract has won the gold award for its third consecutive year at the Monde Selection 2024. ・Snova’s Halal Extract is a skincare product manufactured in accordance with Islamic law (Halal). In Islam, certain ingredients and manufacturing processes are prohibited, so... - May 15, 2024 - Snova Co.

Dr. Pompa Explores the Hidden Risks of Root Canals

Dr. Pompa discusses the hidden risks of root canals in his latest health coaching initiative, revealing that often these procedures may carry infections that affect surrounding tissues. Despite meticulous care, root canals inherently possess risks, suggesting that sometimes avoiding the procedure might be safer. This exploration underscores the importance of careful decision-making and consultation in dental health and wellness. - May 10, 2024 - Pompa Program

New GMP Training with Certificate from Pharma Lessons

Pharma Lessons has launched a brand new Good Manufacturing Practice Training. The new course covers the latest GMP principles and guidelines and is a beautifully designed interactive product that provides both fundamental knowledge and a pleasant experience. The materials are split into 8 separate... - May 09, 2024 - Pharma Lessons

SeabuckWonders Unveils Functional New Product for Women

SeabuckWonders Unveils Functional New Product for Women

Fem-Omega 7 Makes its Debut as Ultimate Supplement for Female Dryness. - May 08, 2024 - SeabuckWonders

Wiser Wellness Awarded Prestigious 2023 BBB Spark Award for Exceptional Leadership and Service in Telemedicine

Wiser Wellness Awarded Prestigious 2023 BBB Spark Award for Exceptional Leadership and Service in Telemedicine

Wiser Wellness is proud to announce that it has won the prestigious 2023 BBB Spark Award for outstanding leadership and service in telemedicine. This honor highlights Wiser Wellness's commitment to integrity, innovation, and community engagement in healthcare. For more on this transformative force in telemedicine, contact Hi@wiserwellness.com. - May 07, 2024 - Wiser Wellness

Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA

Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA

Novugen has launched Pazopanib tablets, 200mg, in the U.S. after receiving ANDA approval from USFDA on April 23, 2024. This significant milestone demonstrates Novugen's continued growth in the U.S. pharmaceutical market with a complex anticancer drug, the generic equivalent of Votrient, used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS). - May 07, 2024 - Novugen

Limited Opportunity:  Enroll in Ales for ALS 2024 Today, Secure Your Spot as Part of a Growing National Movement

Limited Opportunity: Enroll in Ales for ALS 2024 Today, Secure Your Spot as Part of a Growing National Movement

Ales for ALS invites brewers to craft distinctive and flavorful beers using a custom hop blend generously donated by Yakima Chief Hops. In exchange, participating brewers pledge to donate $1 for every pint sold, directly contributing to groundbreaking ALS research at the ALS Therapy Development Institute (ALS TDI). - May 04, 2024 - ALS Therapy Development Institute

Pagari Life Science Corp. Announces the Commercial Launch of Helocaine®, a New Transformative Cold Sore Treatment

Pagari Life Science Corp. Announces the Commercial Launch of Helocaine®, a New Transformative Cold Sore Treatment

Pagari Life Science Corporation is revolutionizing cold sore treatment with the commercial launch of Helocaine®. - May 01, 2024 - Pagari Life Sciences

Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease

Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease

AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu

No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption

No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption

Thar Process, with 34 years of expertise in supercritical fluid extraction, has developed a sustainable way to produce de-fatted lecithin powder that has less oil and longer shelf-life stability. The new process is semi-continuous and sustainable because it utilizes upcycled CO2 from waste sources instead of using toxic acetone which is the industry standard. - April 26, 2024 - Thar Process, LLC

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This... - April 25, 2024 - ALPCO

Creative Biolabs: Summarizing Malaria Infection Mechanisms and Introducing Biotherapeutic Discovery

Creative Biolabs introduced the discovery of biomolecular approaches targeting Plasmodium, aiming to assist academia and the pharmaceutical industry in relieving the malaria health crisis. - April 25, 2024 - Creative Biolabs

New Bonus Chapter for the Certificate GCP Training

Pharma Lessons has added new bonus chapter to their popular International GCP training course. The new chapter covers the main differences in GCP regulations in Spain compared to the international guidelines. The module is voluntary and is not included in the final exam. It is available for all... - April 24, 2024 - Pharma Lessons

Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development

Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development

Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over... - April 18, 2024 - Mirror Biologics, Inc.

Announcing the Launch of the HumaSpan Longevity Supplements Website

Announcing the Launch of the HumaSpan Longevity Supplements Website

HumaSpan Offers a Variety of High Quality Longevity Supplements - April 16, 2024 - HumaSpan

The °C Rail with Slidable Sensors is the Latest Addition to the Degree Controls Platform of Multipoint Airflow Instrumentation

The all-new °C Rail multipoint airflow instrumentation system from Degree Controls is designed with a versatile array of slidable sensors to accommodate changing test setups. - April 15, 2024 - Degree Controls

Nadrich Accident Injury Lawyers Opens New Tulare, CA Office

Nadrich Accident Injury Lawyers, a California personal injury law firm, is proud to announce the opening of its new office in Tulare, CA. - April 13, 2024 - Nadrich & Cohen, LLP

I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression

I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.

Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management

Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron

Huntington Study Group Launches Project AWARE 2.0 Observational Study

Huntington Study Group Launches Project AWARE 2.0 Observational Study

The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group

Minus K Congratulates to the Winners of Their 2023/2024 Educational Giveaway

Minus K congratulates the four winners of the Minus K's 2023/2024 Educational Giveaway. Over $75,000 of new passive mechanical hub hertz vibration isolators have been granted to universities and colleges in the U.S. over the last ten years. - April 10, 2024 - Minus K Technology Inc.

Press Releases 1 - 50 of 8,649